Development of supramolecular anticoagulants with on-demand reversibility
M. Dockerill, D. J. Ford, S. Angerani, I. Alwis, J. Ripoll-Rozada, R. E. Smythe, J. S. T. Liu, P. J. Barbosa Pereira, S. P. Jackson, R. J. Payne, N. Winssinger
This paper develops supramolecular anticoagulants that can be reversed on demand using a PNA antidote, demonstrating potent in vitro and in vivo anticoagulant activity.
bioRxiv · Nov 12, 2023Biochemistry